SALL4 is a new target in endometrial cancer

[1]  D. Kobayashi,et al.  Overexpression of SALL4 in lung cancer and its importance in cell proliferation. , 2011, Oncology reports.

[2]  H. Varmus,et al.  Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis , 2011, Proceedings of the National Academy of Sciences.

[3]  Ha-won Jeong,et al.  SALL4, a Stem Cell Factor, Affects the Side Population by Regulation of the ATP-Binding Cassette Drug Transport Genes , 2011, PloS one.

[4]  D. Kobayashi,et al.  SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer. , 2011, International journal of oncology.

[5]  B. Olsson,et al.  Identification of a gene expression signature for survival prediction in type I endometrial carcinoma. , 2010, Gene expression.

[6]  Clifford A. Meyer,et al.  MYC regulation of a “poor-prognosis” metastatic cancer cell state , 2010, Proceedings of the National Academy of Sciences.

[7]  J. You,et al.  Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression. , 2009, Cancer research.

[8]  P. Humphrey,et al.  SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors , 2009, Cancer.

[9]  Li Chai,et al.  Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[10]  L. Fink,et al.  SALL4 is a key regulator of survival and apoptosis in human leukemic cells. , 2008, Blood.

[11]  I. De Vivo,et al.  Dichloroacetate induces apoptosis in endometrial cancer cells. , 2008, Gynecologic oncology.

[12]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[13]  L. Fink,et al.  Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells , 2007, Proceedings of the National Academy of Sciences.

[14]  T. Eisenberger,et al.  Murine inner cell mass-derived lineages depend on Sall4 function , 2006, Proceedings of the National Academy of Sciences.

[15]  J. Ritz,et al.  SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. , 2006, Blood.

[16]  Li Chai,et al.  Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1 , 2006, Nature Cell Biology.

[17]  X. Chen,et al.  Sall4 Interacts with Nanog and Co-occupies Nanog Genomic Sites in Embryonic Stem Cells* , 2006, Journal of Biological Chemistry.

[18]  H. Aburatani,et al.  The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development , 2006, Development.

[19]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[20]  M. Nguyen,et al.  Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. , 2005, Blood.

[21]  P. Donahoe,et al.  Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  H. Hermeking,et al.  The MYC oncogene as a cancer drug target. , 2003, Current cancer drug targets.

[23]  P. Iversen,et al.  Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model , 2003, Anti-cancer drugs.

[24]  H. Hirte,et al.  Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer , 2002, Current opinion in obstetrics & gynecology.

[25]  P. Fernandez,et al.  Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. , 2001, Genes & development.

[26]  D. Liao,et al.  c-Myc in breast cancer. , 2000, Endocrine-related cancer.

[27]  N. Mulder,et al.  Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines. , 1996, Anticancer research.

[28]  K. Hatch,et al.  Oncogene alterations in endometrial carcinoma. , 1990, Gynecologic oncology.

[29]  J. Minna,et al.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.

[30]  T. Cunha,et al.  Erratum to: Endometrial Cancer , 2017 .

[31]  J. I. Izpisúa Belmonte,et al.  Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. , 2013, The New England journal of medicine.

[32]  N. Munshi,et al.  Dichloroacetate Induces Apoptosis in Endometrial Cancer Cells , 2007 .